Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorTianjin Medical University
About this trial
To evaluate the potential usefulness of 68Ga/18F-PSMA/PSFA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PSMA-related disease patients.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- 68Ga/18F-PSMA/PSFA
Treatment groups
500 Participants
are divided into 1 treatment groupLocations
2The First Affiliated Hospital of University of Science and Technology of China230000, HefeiAnhui, China
Tianjin Medical University General Hospital300052, TianjinTianjin Municipality, China
Sponsors and collaborators
Tianjin Medical University
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Source ClinicalTrials.gov